nodes	percent_of_prediction	percent_of_DWPC	metapath
Pantoprazole—ABCG2—Dactinomycin—muscle cancer	0.143	0.181	CbGbCtD
Pantoprazole—ABCG2—Vincristine—muscle cancer	0.0881	0.112	CbGbCtD
Pantoprazole—ABCG2—Etoposide—muscle cancer	0.0807	0.102	CbGbCtD
Pantoprazole—CYP1A2—Dacarbazine—muscle cancer	0.068	0.0863	CbGbCtD
Pantoprazole—SLCO1B1—Methotrexate—muscle cancer	0.0671	0.0851	CbGbCtD
Pantoprazole—ABCG2—Doxorubicin—muscle cancer	0.0551	0.0698	CbGbCtD
Pantoprazole—ABCG2—Methotrexate—muscle cancer	0.0533	0.0676	CbGbCtD
Pantoprazole—ABCB1—Dactinomycin—muscle cancer	0.0516	0.0654	CbGbCtD
Pantoprazole—CYP1A2—Etoposide—muscle cancer	0.0333	0.0422	CbGbCtD
Pantoprazole—ABCB1—Vincristine—muscle cancer	0.0318	0.0403	CbGbCtD
Pantoprazole—ABCB1—Etoposide—muscle cancer	0.0291	0.0369	CbGbCtD
Pantoprazole—ABCB1—Doxorubicin—muscle cancer	0.0199	0.0252	CbGbCtD
Pantoprazole—ABCB1—Methotrexate—muscle cancer	0.0192	0.0244	CbGbCtD
Pantoprazole—CYP3A4—Vincristine—muscle cancer	0.019	0.0241	CbGbCtD
Pantoprazole—CYP3A4—Etoposide—muscle cancer	0.0174	0.0221	CbGbCtD
Pantoprazole—CYP3A4—Doxorubicin—muscle cancer	0.0119	0.0151	CbGbCtD
Pantoprazole—ATP4A—larynx—muscle cancer	0.00681	0.546	CbGeAlD
Pantoprazole—ATP4A—renal system—muscle cancer	0.00114	0.0913	CbGeAlD
Pantoprazole—ATP4A—head—muscle cancer	0.000762	0.0611	CbGeAlD
Pantoprazole—ATP4A—testis—muscle cancer	0.000736	0.059	CbGeAlD
Pantoprazole—SLCO1B1—renal system—muscle cancer	0.000611	0.049	CbGeAlD
Pantoprazole—CYP1A2—renal system—muscle cancer	0.000325	0.0261	CbGeAlD
Pantoprazole—CYP2C19—vagina—muscle cancer	0.000288	0.0231	CbGeAlD
Pantoprazole—Dysuria—Methotrexate—muscle cancer	0.000261	0.00131	CcSEcCtD
Pantoprazole—Dehydration—Doxorubicin—muscle cancer	0.00026	0.00131	CcSEcCtD
Pantoprazole—Thrombocytopenia—Etoposide—muscle cancer	0.00026	0.00131	CcSEcCtD
Pantoprazole—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000259	0.00131	CcSEcCtD
Pantoprazole—Tachycardia—Etoposide—muscle cancer	0.000259	0.0013	CcSEcCtD
Pantoprazole—Body temperature increased—Vincristine—muscle cancer	0.000259	0.0013	CcSEcCtD
Pantoprazole—Abdominal pain—Vincristine—muscle cancer	0.000259	0.0013	CcSEcCtD
Pantoprazole—Liver function test abnormal—Doxorubicin—muscle cancer	0.000258	0.0013	CcSEcCtD
Pantoprazole—Skin disorder—Etoposide—muscle cancer	0.000257	0.0013	CcSEcCtD
Pantoprazole—Erectile dysfunction—Methotrexate—muscle cancer	0.000257	0.00129	CcSEcCtD
Pantoprazole—Dry skin—Doxorubicin—muscle cancer	0.000256	0.00129	CcSEcCtD
Pantoprazole—Hyperhidrosis—Etoposide—muscle cancer	0.000256	0.00129	CcSEcCtD
Pantoprazole—Abdominal pain upper—Doxorubicin—muscle cancer	0.000255	0.00129	CcSEcCtD
Pantoprazole—ABCG2—bone marrow—muscle cancer	0.000255	0.0205	CbGeAlD
Pantoprazole—Photosensitivity reaction—Methotrexate—muscle cancer	0.000255	0.00128	CcSEcCtD
Pantoprazole—Breast disorder—Doxorubicin—muscle cancer	0.000253	0.00127	CcSEcCtD
Pantoprazole—Anorexia—Etoposide—muscle cancer	0.000253	0.00127	CcSEcCtD
Pantoprazole—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000252	0.00127	CcSEcCtD
Pantoprazole—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000252	0.00127	CcSEcCtD
Pantoprazole—Diarrhoea—Dactinomycin—muscle cancer	0.000251	0.00126	CcSEcCtD
Pantoprazole—Pneumonia—Methotrexate—muscle cancer	0.00025	0.00126	CcSEcCtD
Pantoprazole—Nasopharyngitis—Doxorubicin—muscle cancer	0.00025	0.00126	CcSEcCtD
Pantoprazole—Infestation—Methotrexate—muscle cancer	0.000249	0.00125	CcSEcCtD
Pantoprazole—Infestation NOS—Methotrexate—muscle cancer	0.000249	0.00125	CcSEcCtD
Pantoprazole—Depression—Methotrexate—muscle cancer	0.000248	0.00125	CcSEcCtD
Pantoprazole—Hypotension—Etoposide—muscle cancer	0.000248	0.00125	CcSEcCtD
Pantoprazole—Gastritis—Doxorubicin—muscle cancer	0.000248	0.00125	CcSEcCtD
Pantoprazole—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000247	0.00124	CcSEcCtD
Pantoprazole—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000247	0.00124	CcSEcCtD
Pantoprazole—ABCG2—vagina—muscle cancer	0.000245	0.0196	CbGeAlD
Pantoprazole—Abdominal distension—Doxorubicin—muscle cancer	0.000243	0.00122	CcSEcCtD
Pantoprazole—Stomatitis—Methotrexate—muscle cancer	0.000243	0.00122	CcSEcCtD
Pantoprazole—Conjunctivitis—Methotrexate—muscle cancer	0.000242	0.00122	CcSEcCtD
Pantoprazole—Dysphagia—Doxorubicin—muscle cancer	0.000242	0.00122	CcSEcCtD
Pantoprazole—Asthma—Doxorubicin—muscle cancer	0.000242	0.00122	CcSEcCtD
Pantoprazole—Influenza—Doxorubicin—muscle cancer	0.000242	0.00122	CcSEcCtD
Pantoprazole—Hypersensitivity—Vincristine—muscle cancer	0.000241	0.00121	CcSEcCtD
Pantoprazole—Eosinophilia—Doxorubicin—muscle cancer	0.000239	0.0012	CcSEcCtD
Pantoprazole—Sweating—Methotrexate—muscle cancer	0.000239	0.0012	CcSEcCtD
Pantoprazole—Paraesthesia—Etoposide—muscle cancer	0.000238	0.0012	CcSEcCtD
Pantoprazole—Haematuria—Methotrexate—muscle cancer	0.000237	0.00119	CcSEcCtD
Pantoprazole—Pancreatitis—Doxorubicin—muscle cancer	0.000237	0.00119	CcSEcCtD
Pantoprazole—Dyspnoea—Etoposide—muscle cancer	0.000236	0.00119	CcSEcCtD
Pantoprazole—Somnolence—Etoposide—muscle cancer	0.000236	0.00119	CcSEcCtD
Pantoprazole—Angina pectoris—Doxorubicin—muscle cancer	0.000235	0.00118	CcSEcCtD
Pantoprazole—Hepatobiliary disease—Methotrexate—muscle cancer	0.000235	0.00118	CcSEcCtD
Pantoprazole—CYP3A4—renal system—muscle cancer	0.000235	0.0189	CbGeAlD
Pantoprazole—Epistaxis—Methotrexate—muscle cancer	0.000235	0.00118	CcSEcCtD
Pantoprazole—Asthenia—Vincristine—muscle cancer	0.000235	0.00118	CcSEcCtD
Pantoprazole—Vomiting—Dactinomycin—muscle cancer	0.000233	0.00117	CcSEcCtD
Pantoprazole—Bronchitis—Doxorubicin—muscle cancer	0.000232	0.00117	CcSEcCtD
Pantoprazole—Agranulocytosis—Methotrexate—muscle cancer	0.000232	0.00117	CcSEcCtD
Pantoprazole—Rash—Dactinomycin—muscle cancer	0.000231	0.00116	CcSEcCtD
Pantoprazole—Decreased appetite—Etoposide—muscle cancer	0.00023	0.00116	CcSEcCtD
Pantoprazole—Pancytopenia—Doxorubicin—muscle cancer	0.00023	0.00115	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Etoposide—muscle cancer	0.000229	0.00115	CcSEcCtD
Pantoprazole—Fatigue—Etoposide—muscle cancer	0.000229	0.00115	CcSEcCtD
Pantoprazole—Constipation—Etoposide—muscle cancer	0.000227	0.00114	CcSEcCtD
Pantoprazole—Pain—Etoposide—muscle cancer	0.000227	0.00114	CcSEcCtD
Pantoprazole—Dysuria—Doxorubicin—muscle cancer	0.000226	0.00114	CcSEcCtD
Pantoprazole—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000225	0.00113	CcSEcCtD
Pantoprazole—Haemoglobin—Methotrexate—muscle cancer	0.000225	0.00113	CcSEcCtD
Pantoprazole—Diarrhoea—Vincristine—muscle cancer	0.000224	0.00113	CcSEcCtD
Pantoprazole—Hepatitis—Methotrexate—muscle cancer	0.000223	0.00112	CcSEcCtD
Pantoprazole—Haemorrhage—Methotrexate—muscle cancer	0.000223	0.00112	CcSEcCtD
Pantoprazole—Pollakiuria—Doxorubicin—muscle cancer	0.000223	0.00112	CcSEcCtD
Pantoprazole—Pharyngitis—Methotrexate—muscle cancer	0.000222	0.00112	CcSEcCtD
Pantoprazole—Urinary tract disorder—Methotrexate—muscle cancer	0.000221	0.00111	CcSEcCtD
Pantoprazole—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000221	0.00111	CcSEcCtD
Pantoprazole—Weight increased—Doxorubicin—muscle cancer	0.00022	0.00111	CcSEcCtD
Pantoprazole—ABCB1—embryo—muscle cancer	0.00022	0.0176	CbGeAlD
Pantoprazole—Urethral disorder—Methotrexate—muscle cancer	0.000219	0.0011	CcSEcCtD
Pantoprazole—Weight decreased—Doxorubicin—muscle cancer	0.000219	0.0011	CcSEcCtD
Pantoprazole—Feeling abnormal—Etoposide—muscle cancer	0.000218	0.0011	CcSEcCtD
Pantoprazole—ABCG2—testis—muscle cancer	0.000218	0.0175	CbGeAlD
Pantoprazole—Hyperglycaemia—Doxorubicin—muscle cancer	0.000218	0.0011	CcSEcCtD
Pantoprazole—Nausea—Dactinomycin—muscle cancer	0.000218	0.00109	CcSEcCtD
Pantoprazole—Pneumonia—Doxorubicin—muscle cancer	0.000217	0.00109	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Etoposide—muscle cancer	0.000217	0.00109	CcSEcCtD
Pantoprazole—Dizziness—Vincristine—muscle cancer	0.000216	0.00109	CcSEcCtD
Pantoprazole—Infestation NOS—Doxorubicin—muscle cancer	0.000216	0.00108	CcSEcCtD
Pantoprazole—Infestation—Doxorubicin—muscle cancer	0.000216	0.00108	CcSEcCtD
Pantoprazole—Visual impairment—Methotrexate—muscle cancer	0.000215	0.00108	CcSEcCtD
Pantoprazole—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000214	0.00107	CcSEcCtD
Pantoprazole—Erythema multiforme—Methotrexate—muscle cancer	0.000211	0.00106	CcSEcCtD
Pantoprazole—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000211	0.00106	CcSEcCtD
Pantoprazole—Urticaria—Etoposide—muscle cancer	0.000211	0.00106	CcSEcCtD
Pantoprazole—Stomatitis—Doxorubicin—muscle cancer	0.00021	0.00106	CcSEcCtD
Pantoprazole—Jaundice—Doxorubicin—muscle cancer	0.00021	0.00106	CcSEcCtD
Pantoprazole—Body temperature increased—Etoposide—muscle cancer	0.00021	0.00105	CcSEcCtD
Pantoprazole—Abdominal pain—Etoposide—muscle cancer	0.00021	0.00105	CcSEcCtD
Pantoprazole—Conjunctivitis—Doxorubicin—muscle cancer	0.00021	0.00105	CcSEcCtD
Pantoprazole—Urinary tract infection—Doxorubicin—muscle cancer	0.00021	0.00105	CcSEcCtD
Pantoprazole—Eye disorder—Methotrexate—muscle cancer	0.000209	0.00105	CcSEcCtD
Pantoprazole—Tinnitus—Methotrexate—muscle cancer	0.000208	0.00105	CcSEcCtD
Pantoprazole—Vomiting—Vincristine—muscle cancer	0.000208	0.00105	CcSEcCtD
Pantoprazole—Sweating—Doxorubicin—muscle cancer	0.000207	0.00104	CcSEcCtD
Pantoprazole—Rash—Vincristine—muscle cancer	0.000206	0.00104	CcSEcCtD
Pantoprazole—Dermatitis—Vincristine—muscle cancer	0.000206	0.00104	CcSEcCtD
Pantoprazole—Haematuria—Doxorubicin—muscle cancer	0.000206	0.00103	CcSEcCtD
Pantoprazole—Headache—Vincristine—muscle cancer	0.000205	0.00103	CcSEcCtD
Pantoprazole—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000204	0.00103	CcSEcCtD
Pantoprazole—Epistaxis—Doxorubicin—muscle cancer	0.000203	0.00102	CcSEcCtD
Pantoprazole—Sinusitis—Doxorubicin—muscle cancer	0.000202	0.00102	CcSEcCtD
Pantoprazole—Immune system disorder—Methotrexate—muscle cancer	0.000202	0.00102	CcSEcCtD
Pantoprazole—Agranulocytosis—Doxorubicin—muscle cancer	0.000201	0.00101	CcSEcCtD
Pantoprazole—Chills—Methotrexate—muscle cancer	0.000201	0.00101	CcSEcCtD
Pantoprazole—Alopecia—Methotrexate—muscle cancer	0.000197	0.000993	CcSEcCtD
Pantoprazole—Mental disorder—Methotrexate—muscle cancer	0.000196	0.000985	CcSEcCtD
Pantoprazole—Hypersensitivity—Etoposide—muscle cancer	0.000195	0.000982	CcSEcCtD
Pantoprazole—Malnutrition—Methotrexate—muscle cancer	0.000195	0.000979	CcSEcCtD
Pantoprazole—Haemoglobin—Doxorubicin—muscle cancer	0.000194	0.000978	CcSEcCtD
Pantoprazole—Nausea—Vincristine—muscle cancer	0.000194	0.000978	CcSEcCtD
Pantoprazole—Rhinitis—Doxorubicin—muscle cancer	0.000194	0.000976	CcSEcCtD
Pantoprazole—Hepatitis—Doxorubicin—muscle cancer	0.000194	0.000973	CcSEcCtD
Pantoprazole—Haemorrhage—Doxorubicin—muscle cancer	0.000194	0.000973	CcSEcCtD
Pantoprazole—Hypoaesthesia—Doxorubicin—muscle cancer	0.000193	0.000968	CcSEcCtD
Pantoprazole—Pharyngitis—Doxorubicin—muscle cancer	0.000192	0.000966	CcSEcCtD
Pantoprazole—Urinary tract disorder—Doxorubicin—muscle cancer	0.000191	0.000961	CcSEcCtD
Pantoprazole—Oedema peripheral—Doxorubicin—muscle cancer	0.000191	0.000959	CcSEcCtD
Pantoprazole—Dysgeusia—Methotrexate—muscle cancer	0.00019	0.000958	CcSEcCtD
Pantoprazole—Asthenia—Etoposide—muscle cancer	0.00019	0.000957	CcSEcCtD
Pantoprazole—Connective tissue disorder—Doxorubicin—muscle cancer	0.00019	0.000957	CcSEcCtD
Pantoprazole—Urethral disorder—Doxorubicin—muscle cancer	0.00019	0.000954	CcSEcCtD
Pantoprazole—Back pain—Methotrexate—muscle cancer	0.000188	0.000947	CcSEcCtD
Pantoprazole—Pruritus—Etoposide—muscle cancer	0.000188	0.000943	CcSEcCtD
Pantoprazole—Visual impairment—Doxorubicin—muscle cancer	0.000186	0.000938	CcSEcCtD
Pantoprazole—Vision blurred—Methotrexate—muscle cancer	0.000183	0.000922	CcSEcCtD
Pantoprazole—Erythema multiforme—Doxorubicin—muscle cancer	0.000183	0.00092	CcSEcCtD
Pantoprazole—Diarrhoea—Etoposide—muscle cancer	0.000181	0.000912	CcSEcCtD
Pantoprazole—Eye disorder—Doxorubicin—muscle cancer	0.000181	0.00091	CcSEcCtD
Pantoprazole—Ill-defined disorder—Methotrexate—muscle cancer	0.00018	0.000908	CcSEcCtD
Pantoprazole—Tinnitus—Doxorubicin—muscle cancer	0.00018	0.000908	CcSEcCtD
Pantoprazole—Anaemia—Methotrexate—muscle cancer	0.00018	0.000904	CcSEcCtD
Pantoprazole—Flushing—Doxorubicin—muscle cancer	0.00018	0.000903	CcSEcCtD
Pantoprazole—Malaise—Methotrexate—muscle cancer	0.000175	0.000882	CcSEcCtD
Pantoprazole—Dizziness—Etoposide—muscle cancer	0.000175	0.000882	CcSEcCtD
Pantoprazole—Immune system disorder—Doxorubicin—muscle cancer	0.000175	0.000879	CcSEcCtD
Pantoprazole—Vertigo—Methotrexate—muscle cancer	0.000175	0.000879	CcSEcCtD
Pantoprazole—Leukopenia—Methotrexate—muscle cancer	0.000174	0.000876	CcSEcCtD
Pantoprazole—Chills—Doxorubicin—muscle cancer	0.000174	0.000873	CcSEcCtD
Pantoprazole—Arrhythmia—Doxorubicin—muscle cancer	0.000173	0.00087	CcSEcCtD
Pantoprazole—Alopecia—Doxorubicin—muscle cancer	0.000171	0.00086	CcSEcCtD
Pantoprazole—Cough—Methotrexate—muscle cancer	0.00017	0.000854	CcSEcCtD
Pantoprazole—Mental disorder—Doxorubicin—muscle cancer	0.00017	0.000853	CcSEcCtD
Pantoprazole—Convulsion—Methotrexate—muscle cancer	0.000169	0.000848	CcSEcCtD
Pantoprazole—Vomiting—Etoposide—muscle cancer	0.000169	0.000848	CcSEcCtD
Pantoprazole—Malnutrition—Doxorubicin—muscle cancer	0.000168	0.000847	CcSEcCtD
Pantoprazole—Rash—Etoposide—muscle cancer	0.000167	0.000841	CcSEcCtD
Pantoprazole—Dermatitis—Etoposide—muscle cancer	0.000167	0.00084	CcSEcCtD
Pantoprazole—ABCB1—renal system—muscle cancer	0.000166	0.0133	CbGeAlD
Pantoprazole—Headache—Etoposide—muscle cancer	0.000166	0.000835	CcSEcCtD
Pantoprazole—Flatulence—Doxorubicin—muscle cancer	0.000166	0.000835	CcSEcCtD
Pantoprazole—Chest pain—Methotrexate—muscle cancer	0.000166	0.000833	CcSEcCtD
Pantoprazole—Arthralgia—Methotrexate—muscle cancer	0.000166	0.000833	CcSEcCtD
Pantoprazole—Myalgia—Methotrexate—muscle cancer	0.000166	0.000833	CcSEcCtD
Pantoprazole—Tension—Doxorubicin—muscle cancer	0.000165	0.000831	CcSEcCtD
Pantoprazole—Dysgeusia—Doxorubicin—muscle cancer	0.000165	0.00083	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000164	0.000827	CcSEcCtD
Pantoprazole—Discomfort—Methotrexate—muscle cancer	0.000164	0.000823	CcSEcCtD
Pantoprazole—Nervousness—Doxorubicin—muscle cancer	0.000164	0.000823	CcSEcCtD
Pantoprazole—Back pain—Doxorubicin—muscle cancer	0.000163	0.00082	CcSEcCtD
Pantoprazole—Muscle spasms—Doxorubicin—muscle cancer	0.000162	0.000815	CcSEcCtD
Pantoprazole—Confusional state—Methotrexate—muscle cancer	0.00016	0.000805	CcSEcCtD
Pantoprazole—Anaphylactic shock—Methotrexate—muscle cancer	0.000159	0.000799	CcSEcCtD
Pantoprazole—Vision blurred—Doxorubicin—muscle cancer	0.000159	0.000799	CcSEcCtD
Pantoprazole—Infection—Methotrexate—muscle cancer	0.000158	0.000793	CcSEcCtD
Pantoprazole—Nausea—Etoposide—muscle cancer	0.000157	0.000792	CcSEcCtD
Pantoprazole—Ill-defined disorder—Doxorubicin—muscle cancer	0.000156	0.000786	CcSEcCtD
Pantoprazole—Nervous system disorder—Methotrexate—muscle cancer	0.000156	0.000783	CcSEcCtD
Pantoprazole—Anaemia—Doxorubicin—muscle cancer	0.000156	0.000783	CcSEcCtD
Pantoprazole—Thrombocytopenia—Methotrexate—muscle cancer	0.000155	0.000782	CcSEcCtD
Pantoprazole—Agitation—Doxorubicin—muscle cancer	0.000155	0.000779	CcSEcCtD
Pantoprazole—Skin disorder—Methotrexate—muscle cancer	0.000154	0.000776	CcSEcCtD
Pantoprazole—Hyperhidrosis—Methotrexate—muscle cancer	0.000153	0.000772	CcSEcCtD
Pantoprazole—Malaise—Doxorubicin—muscle cancer	0.000152	0.000764	CcSEcCtD
Pantoprazole—Vertigo—Doxorubicin—muscle cancer	0.000151	0.000761	CcSEcCtD
Pantoprazole—Anorexia—Methotrexate—muscle cancer	0.000151	0.000761	CcSEcCtD
Pantoprazole—Syncope—Doxorubicin—muscle cancer	0.000151	0.00076	CcSEcCtD
Pantoprazole—Leukopenia—Doxorubicin—muscle cancer	0.000151	0.000758	CcSEcCtD
Pantoprazole—Palpitations—Doxorubicin—muscle cancer	0.000149	0.000749	CcSEcCtD
Pantoprazole—Hypotension—Methotrexate—muscle cancer	0.000148	0.000746	CcSEcCtD
Pantoprazole—Loss of consciousness—Doxorubicin—muscle cancer	0.000148	0.000745	CcSEcCtD
Pantoprazole—Cough—Doxorubicin—muscle cancer	0.000147	0.000739	CcSEcCtD
Pantoprazole—Convulsion—Doxorubicin—muscle cancer	0.000146	0.000734	CcSEcCtD
Pantoprazole—Hypertension—Doxorubicin—muscle cancer	0.000145	0.000732	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000145	0.000728	CcSEcCtD
Pantoprazole—Insomnia—Methotrexate—muscle cancer	0.000144	0.000722	CcSEcCtD
Pantoprazole—Chest pain—Doxorubicin—muscle cancer	0.000143	0.000721	CcSEcCtD
Pantoprazole—Arthralgia—Doxorubicin—muscle cancer	0.000143	0.000721	CcSEcCtD
Pantoprazole—Myalgia—Doxorubicin—muscle cancer	0.000143	0.000721	CcSEcCtD
Pantoprazole—Anxiety—Doxorubicin—muscle cancer	0.000143	0.000719	CcSEcCtD
Pantoprazole—Paraesthesia—Methotrexate—muscle cancer	0.000143	0.000717	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000142	0.000716	CcSEcCtD
Pantoprazole—Discomfort—Doxorubicin—muscle cancer	0.000142	0.000713	CcSEcCtD
Pantoprazole—Dyspnoea—Methotrexate—muscle cancer	0.000142	0.000712	CcSEcCtD
Pantoprazole—Somnolence—Methotrexate—muscle cancer	0.000141	0.00071	CcSEcCtD
Pantoprazole—Dry mouth—Doxorubicin—muscle cancer	0.00014	0.000706	CcSEcCtD
Pantoprazole—Dyspepsia—Methotrexate—muscle cancer	0.00014	0.000703	CcSEcCtD
Pantoprazole—Confusional state—Doxorubicin—muscle cancer	0.000139	0.000697	CcSEcCtD
Pantoprazole—Decreased appetite—Methotrexate—muscle cancer	0.000138	0.000694	CcSEcCtD
Pantoprazole—Anaphylactic shock—Doxorubicin—muscle cancer	0.000137	0.000692	CcSEcCtD
Pantoprazole—Oedema—Doxorubicin—muscle cancer	0.000137	0.000692	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000137	0.000689	CcSEcCtD
Pantoprazole—Fatigue—Methotrexate—muscle cancer	0.000137	0.000689	CcSEcCtD
Pantoprazole—Infection—Doxorubicin—muscle cancer	0.000137	0.000687	CcSEcCtD
Pantoprazole—Pain—Methotrexate—muscle cancer	0.000136	0.000683	CcSEcCtD
Pantoprazole—Shock—Doxorubicin—muscle cancer	0.000135	0.00068	CcSEcCtD
Pantoprazole—Nervous system disorder—Doxorubicin—muscle cancer	0.000135	0.000678	CcSEcCtD
Pantoprazole—Thrombocytopenia—Doxorubicin—muscle cancer	0.000135	0.000677	CcSEcCtD
Pantoprazole—Tachycardia—Doxorubicin—muscle cancer	0.000134	0.000675	CcSEcCtD
Pantoprazole—Skin disorder—Doxorubicin—muscle cancer	0.000134	0.000672	CcSEcCtD
Pantoprazole—Hyperhidrosis—Doxorubicin—muscle cancer	0.000133	0.000669	CcSEcCtD
Pantoprazole—Anorexia—Doxorubicin—muscle cancer	0.000131	0.000659	CcSEcCtD
Pantoprazole—Feeling abnormal—Methotrexate—muscle cancer	0.000131	0.000658	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Methotrexate—muscle cancer	0.00013	0.000653	CcSEcCtD
Pantoprazole—Hypotension—Doxorubicin—muscle cancer	0.000128	0.000646	CcSEcCtD
Pantoprazole—Urticaria—Methotrexate—muscle cancer	0.000126	0.000634	CcSEcCtD
Pantoprazole—ABCB1—bone marrow—muscle cancer	0.000126	0.0101	CbGeAlD
Pantoprazole—Body temperature increased—Methotrexate—muscle cancer	0.000126	0.000631	CcSEcCtD
Pantoprazole—Abdominal pain—Methotrexate—muscle cancer	0.000126	0.000631	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000125	0.00063	CcSEcCtD
Pantoprazole—Insomnia—Doxorubicin—muscle cancer	0.000124	0.000625	CcSEcCtD
Pantoprazole—Paraesthesia—Doxorubicin—muscle cancer	0.000123	0.000621	CcSEcCtD
Pantoprazole—Dyspnoea—Doxorubicin—muscle cancer	0.000123	0.000617	CcSEcCtD
Pantoprazole—Somnolence—Doxorubicin—muscle cancer	0.000122	0.000615	CcSEcCtD
Pantoprazole—Dyspepsia—Doxorubicin—muscle cancer	0.000121	0.000609	CcSEcCtD
Pantoprazole—ABCB1—vagina—muscle cancer	0.000121	0.00967	CbGeAlD
Pantoprazole—Decreased appetite—Doxorubicin—muscle cancer	0.00012	0.000601	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000119	0.000597	CcSEcCtD
Pantoprazole—Fatigue—Doxorubicin—muscle cancer	0.000119	0.000596	CcSEcCtD
Pantoprazole—Constipation—Doxorubicin—muscle cancer	0.000118	0.000591	CcSEcCtD
Pantoprazole—Pain—Doxorubicin—muscle cancer	0.000118	0.000591	CcSEcCtD
Pantoprazole—Hypersensitivity—Methotrexate—muscle cancer	0.000117	0.000588	CcSEcCtD
Pantoprazole—Asthenia—Methotrexate—muscle cancer	0.000114	0.000573	CcSEcCtD
Pantoprazole—Feeling abnormal—Doxorubicin—muscle cancer	0.000113	0.00057	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000112	0.000565	CcSEcCtD
Pantoprazole—Pruritus—Methotrexate—muscle cancer	0.000112	0.000565	CcSEcCtD
Pantoprazole—ABCB1—head—muscle cancer	0.000111	0.00893	CbGeAlD
Pantoprazole—Urticaria—Doxorubicin—muscle cancer	0.000109	0.000549	CcSEcCtD
Pantoprazole—Body temperature increased—Doxorubicin—muscle cancer	0.000109	0.000547	CcSEcCtD
Pantoprazole—Abdominal pain—Doxorubicin—muscle cancer	0.000109	0.000547	CcSEcCtD
Pantoprazole—Diarrhoea—Methotrexate—muscle cancer	0.000109	0.000546	CcSEcCtD
Pantoprazole—ABCB1—testis—muscle cancer	0.000108	0.00863	CbGeAlD
Pantoprazole—Dizziness—Methotrexate—muscle cancer	0.000105	0.000528	CcSEcCtD
Pantoprazole—Hypersensitivity—Doxorubicin—muscle cancer	0.000101	0.000509	CcSEcCtD
Pantoprazole—Vomiting—Methotrexate—muscle cancer	0.000101	0.000508	CcSEcCtD
Pantoprazole—Rash—Methotrexate—muscle cancer	0.0001	0.000504	CcSEcCtD
Pantoprazole—Dermatitis—Methotrexate—muscle cancer	0.0001	0.000503	CcSEcCtD
Pantoprazole—Headache—Methotrexate—muscle cancer	9.95e-05	0.0005	CcSEcCtD
Pantoprazole—Asthenia—Doxorubicin—muscle cancer	9.86e-05	0.000496	CcSEcCtD
Pantoprazole—Pruritus—Doxorubicin—muscle cancer	9.73e-05	0.000489	CcSEcCtD
Pantoprazole—Nausea—Methotrexate—muscle cancer	9.43e-05	0.000474	CcSEcCtD
Pantoprazole—Diarrhoea—Doxorubicin—muscle cancer	9.41e-05	0.000473	CcSEcCtD
Pantoprazole—Dizziness—Doxorubicin—muscle cancer	9.09e-05	0.000457	CcSEcCtD
Pantoprazole—Vomiting—Doxorubicin—muscle cancer	8.74e-05	0.00044	CcSEcCtD
Pantoprazole—Rash—Doxorubicin—muscle cancer	8.67e-05	0.000436	CcSEcCtD
Pantoprazole—Dermatitis—Doxorubicin—muscle cancer	8.66e-05	0.000436	CcSEcCtD
Pantoprazole—Headache—Doxorubicin—muscle cancer	8.61e-05	0.000433	CcSEcCtD
Pantoprazole—Nausea—Doxorubicin—muscle cancer	8.17e-05	0.000411	CcSEcCtD
